Down-Regulation of Treg Cells and Up-Regulation of Th1/Th2 Cytokine Ratio Were Induced by Polysaccharide from Radix Glycyrrhizae in H22 Hepatocarcinoma Bearing Mice

Xiaojuan He; Xiaobing Li; Biao Liu; Li Xu; Hongyan Zhao; Aiping Lu
October 2011
Molecules;Oct2011, Vol. 16 Issue 10, p8343
Academic Journal
Radix Glycyrrhizae polysaccharide (GP) possesses multiple pharmacological activities. However, the effect of GP on CD4+CD25+ regulatory T (Treg) cells has not been elucidated. This study aimed to investigate the effects of GP on Treg cells and Th1/Th2 cytokines in H22 hepatocarcinoma tumor-bearing mice. The results demonstrated that GP inhibits tumor progression. In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice. GP administration down-regulated the population of Treg cells (P < 0.01) and decreased lymph node Foxp3 and IL-10 mRNA expression (P < 0.01). In addition, GP treatment decreased IL-10 and TGF-β level (P < 0.01) and increased IL-2 and IL-12p70 level in serum (P < 0.01). In conclusion, GP reduced the proportion of Treg cells and Foxp3 lowered expression in Treg cells, and up-regulated Th1/Th2 cytokine ratio in serum in the tumor bearing mice, which might partially cause the inhibition of tumor growth.


Related Articles

  • Lymph-node metastases in rectal carcinoids. Fujimoto, Yoshiya; Oya, Masatoshi; Kuroyanagi, Hiroya; Ueno, Masashi; Akiyoshi, Takashi; Yamaguchi, Toshiharu; Muto, Tetsuichiro // Langenbeck's Archives of Surgery;Feb2010, Vol. 395 Issue 2, p139 

    Colorectal carcinoids are described as low-grade malignancy in the WHO classification. However, the survival is equally poor between carcinoids and adenocarcinomas if the tumors have lymph node metastasis or distant metastasis. We reviewed 17 patients with rectal carcinoid, who underwent...

  • Size surprise? Tumour size, nodal status, and outcome after breast cancer. Foulkes, W. D. // Current Oncology;Oct2012, Vol. 19 Issue 5, p241 

    The article discusses the size of tumour, the status of lymph node, and outcome after breast cancer. It focuses on the high correlation of tumour size and axillary lymph node status, but they are independent measures of outcome. Moreover, it notes that the outcome is worse if the greater number...

  • Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells. Suen, Jacky Y.; Gardiner, Brooke; Grimmond, Sean; Fairlie, David P. // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Protease-Activated Receptor-2 (PAR2) has been implicated through genetic knockout mice with cytokine regulation and arthritis development. Many studies have associated PAR2 with inflammatory conditions (arthritis, airways inflammation, IBD) and key events in tumor progression (angiogenesis,...

  • Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression. Du, Gangjun; Zhao, Bei; Zhang, Yaping; Sun, Ting; Liu, Weijie; Li, Jiahuan; Liu, Yinghui; Wang, Yingying; Li, Hong; Hou, Xidong // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Microenvironment has been increasingly recognized as a critical regulator of cancer progression. In this study, we identified early changes in the microenvironment that contribute to malignant progression. Exposure of human bronchial epithelial cells (BEAS-2B) to methylnitrosourea (MNU) caused a...

  • Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin. Xuesong Wu; Sells, Ryan E.; Hwang, Sam T. // Journal of Investigative Dermatology;Aug2011, Vol. 131 Issue 8, p1727 

    The tumor microenvironment, including its inflammatory components, regulates tumor progression. Herein, we explore the relationship between inflammation and the progression of T-cell lymphoma in the cutaneous microenvironment. Injection of MBL2 murine T lymphoma cells into ear skin of C57BL/6...

  • Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link. Conroy, H.; Mawhinney, L.; Donnelly, S. C. // QJM: An International Journal of Medicine;Nov2010, Vol. 103 Issue 11, p831 

    Macrophage migration inhibitory factor (MIF) was the original cytokine, described almost 50 years ago and has since been revealed to be an important player in pro-inflammatory diseases. Recent work using MIF mouse models has revealed new roles for MIF. In this review, we present an increasing...

  • IL-11 is a parietal cell cytokine that induces atrophic gastritis. Howlett, Meegan; Chalinor, Heather V.; Buzzelli, Jon N.; Nguyen, Nhung; van Driel, Ian R.; Bell, Katrina M.; Fox, James G.; Dimitriadis, Eva; Menheniott, Trevelyan R.; Giraud, Andrew S.; Judd, Louise M. // Gut;Oct2012, Vol. 61 Issue 10, p1398 

    Background and Aims IL-is important in gastric damage, mucosal repair and gastric cancer progression. We analysed IL-11 expression in H.pylori infected mouse stomach, the site of gastric IL-11 expression in mice and humans, and the effect of exogenous IL-11 on gastric mucosal homeostasis....

  • The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Soto, Brenda; Hank, Jacquelyn; Voort, Tyler; Subramanian, Lalita; Polans, Arthur; Rakhmilevich, Alexander; Yang, Richard; Seo, Songwong; Kim, KyungMann; Reisfeld, Ralph; Gillies, Stephen; Sondel, Paul // Cancer Immunology, Immunotherapy;May2011, Vol. 60 Issue 5, p731 

    We investigated the anti-tumor effect of peritumoral resveratrol in combination with immunotherapy in vivo in neuroblastoma-bearing mice. Subcutaneous NXS2 tumors were induced in A/J mice. On day 10, some mice received 15 mcg of intravenous immunocytokine for 5 days, mice received 20 mg of...

  • A pilot study on acute inflammation and cancer: a new balance between IFN-γ and TGF-β in melanoma. Yue-mei Ma; Tao Sun; Yi-xin Liu; Nan Zhao; Qiang Gu; Danfang Zhang; Shuo Qie; Chun-sheng Ni; Yi Liu; Bao-cun Sun // Journal of Experimental & Clinical Cancer Research (17569966);2009, Vol. 28, p1 

    Recent data have redefined the concept of inflammation as a critical component of tumor progression. However, there has been little development on cases where inflammation on or near a wound and a tumor exist simultaneously. Therefore, this pilot study aims to observe the impact of a wound on a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics